InvAscent
Healthcare
InvAscent's third fund strikes two more deals; hits final close
Healthcare private equity firm InvAscent has struck two new deals from its third fund that just marked its final close, ......
Healthcare
InvAscent topping up oversubscribed healthcare PE fund
Healthcare private equity firm InvAscent is set to add more money to its India-focused third fund before hitting the final ......
Healthcare
Tata Capital targets bigger corpus for second healthcare private equity fund
Tata Capital Ltd has formally kicked off a process to mobilise capital for its second healthcare private equity fund, targeting ......
Healthcare
Mid-market PE consortium in talks to buy Actis' stake in Symbiotec
Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......
Healthcare
Evolvence India Life Sciences Fund fully exits Chennai drugmaker
Evolvence India Life Sciences Fund, the debut healthcare fund managed by private equity firm InvAscent, has fully exited its nine-year-old ......
Healthcare
India Life Sciences Fund makes new pharma bet
India Life Sciences Fund II, which is advised by InvAscent India, has struck a new deal in the pharmaceuticals sector ......
Finance
Healthcare-focussed PE firm InvAscent's third fund oversubscribed
Healthcare-focussed private equity firm InvAscent is aiming to mark the final close of its third fund next month after surpassing ......
Healthcare
India Life Sciences Fund II makes new pharma bet
Healthcare-focussed private equity fund India Life Sciences Fund II, which is advised by InvAscent India, has struck a new deal ......
Healthcare
How scalable are IVF firms for PE/VC investments amid regulatory uncertainty?
Just a couple of months after the Cabinet approved a bill to ban commercial surrogacy, two contrasting developments occurred in ......